Company Overview and News

 
Completion of Fundraise, TVR & Director's Dealings

2017-05-08 londonstockexchange
Regency Mines plc (AIM:RGM) the natural resource exploration, investment and development company announces that further to the announcement of 05 May 2017 the proposed fundraise through the Teathers mobile application, opened at 5 .p.m on the evening of 5 May 2017 (the "Fundraise"), has been completed successfully.
Upvote Downvote

 
Proposed fundraise through the Teathers App

2017-05-05 londonstockexchange
Regency Mines announces that it proposes to raise up to £110,000 (the "proposed fundraise") through the Teathers mobile application (the "Teathers App"). This will involve the issue of up to 12,222,223 new ordinary shares of 0.01p each at a price of 0.9p per ordinary share on the same terms as described in the "Project Update, Placing and TVR" announcement of 02 May 2017, together with the 1 for 1 warrants exercisable at a price of 1.
Upvote Downvote

 
Project Update, Placing and TVR

2017-05-03 londonstockexchange
Regency Mines plc (AIM:RGM) the natural resource exploration, investment and development company  provides an update on the current implementation of first commercial coal production and also announces it has raised £306,000 to enable further acceleration of the Company's expansion plans.
Upvote Downvote

 
Exercise of Warrants, Total Voting Rights

2017-04-21 londonstockexchange
Regency Mines plc announces that it has received notices of the exercise of 2,175,000 warrants into 2,175,000 new ordinary shares of 0.01 pence each ("Shares") in the Company at an exercise price of 0.8p per share, for gross proceeds of £17,400.
Upvote Downvote

 
Coal Update

2017-04-20 londonstockexchange
Regency Mines Plc announces, further to the announcements of 27th March and 9th March 2017, progress at the Rosa metallurgical coal mine ("Rosa", held through Carbon Minerals Corporation or "CMC") located in Alabama, United States of America, in the Warrior Coal Basin, and at Vali Carbon Corporation ("VCC"). Regency owns 20% of CMC and 20% of VCC.
Upvote Downvote

 
Exercise of Warrants, Total Voting Rights

2017-04-10 londonstockexchange
Regency Mines plc announces that it has received notice of the exercise of 500,000 warrants into 500,000 new ordinary shares of 0.01 pence each ("Shares") in the Company at an exercise price of 0.8p per share, for gross proceeds of £4,000.
Upvote Downvote

 
Exercise of Warrants and Total Voting Rights

2017-03-28 londonstockexchange
Regency Mines plc announces that it has received notices of the exercise of 3,750,000 warrants into 3,750,000 new ordinary shares of 0.01 pence each ("Shares") in the Company at an exercise price of 0.8p per share, for gross proceeds of £30,000.
Upvote Downvote

 
Rosa Mine - Update

2017-03-27 londonstockexchange
Regency Mines Plc announces, further to the announcements of 27th February and 9th March 2017, progress at Carbon Minerals Corporation's Rosa metallurgical coal mine ("CMC" and "Rosa") located in Alabama, United States of America, in the Warrior Coal Basin. Regency owns 20% of CMC.
Upvote Downvote

 
Exercise of Warrants, Total Voting Rights

2017-03-21 londonstockexchange
Regency Mines plc announces that it has received notice of the exercise of 4,000,000 warrants into 4,000,000 new ordinary shares of 0.01 pence each ("Shares") in the Company at an exercise price of 0.8p per share, for gross proceeds of £32,000.
Upvote Downvote

 
Exercise of Warrants, Total Voting Rights

2017-03-20 londonstockexchange
Regency Mines plc announces that it has received notice of the exercise of 625,000 warrants into 625,000 new ordinary shares of 0.01 pence each ("Shares") in the Company at an exercise price of 0.8p per share, for gross proceeds of £5,000.
Upvote Downvote

 
Exercise of Warrants, Total Voting Rights

2017-03-02 londonstockexchange
Regency Mines plc announces that it has received notice of the exercise of 17,898,183 warrants into 17,898,183 new ordinary shares of 0.01 pence each ("Shares") in the Company at an exercise price of 0.39p per share, for gross proceeds of £69,803.
Upvote Downvote

 
Exercise of Warrants, Total Voting Rights

2017-02-28 londonstockexchange
Regency Mines plc announces that it has received notice of the exercise of 18,125,000 warrants into 18,125,000 new ordinary shares of 0.01 pence each ("Shares") in the Company at an exercise price of 0.8p per share, for gross proceeds of £145,000.
Upvote Downvote

 
Coal - Update

2017-02-27 londonstockexchange
Regency Mines Plc announces, further to the announcement of 6th February 2017, progress at Carbon Minerals Corporation's Rosa metallurgical coal mine ("CMC" and "Rosa") located in Alabama, United States of America, in the Warrior Coal Basin, including the signing of coal offtake agreements. Regency owns 20% of CMC.
Upvote Downvote

 
Grant of Option over Motzfeldt, Issue of Equity

2017-02-22 londonstockexchange
Regency Mines plc announces that it has granted a four month option to Value Generation Limited,a private company (the "Option" and the "Optionor"/"VGL") to acquire the Company's 100% interest in license 2014/01 covering the Motzfeldt intrusive complex in southern Greenland ("Motzfeldt").As a condition of the Option, VGL has also subscribed £75,000 for new shares in Regency ("Subscription").
Upvote Downvote

 
Issue of Equity and TVR

2017-02-08 londonstockexchange
Regency Mines plc announces that it has raised £105,000 by way of a placing of 21,000,000 new ordinary shares of 0.01 pence each ("Shares") in the Company at a price of 0.5p per share with 1 for 1 warrants exercisable at a price of 1p for twenty-four months ("March 2019 Warrants" and "Placing").
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...